Olivia Dutton

Olivia joined us as a PhD student in October 2026 and will be working on an AstraZeneca-funded PhD project aimed to develop better approaches for expressing recombinant proteins using a combination of cell line engineering and machine learning.

Biography

Liv holds a BSc in Biological Sciences from the University of Warwick and is currently undertaking an AstraZeneca-funded, non-clinical PhD studentship on the project 'Matchmaker: Prioritising the Best Cell Line for Expressing Target Proteins Using CRISPR and Machine Learning'.

Research positions

PhD student (Oct 2026 - now)
Department of Biochemistry, University of Cambridge, in collaboration with AstraZeneca

Graduate Scientist (Sep 2024 - Dec 2025)
Translational Biomarkers, Neuroscience Discovery at MSD in the UK

BSc Project Student (Oct 2023 - Jun 2024)
School of Life Sciences, University of Warwick

Industrial Placement Student (Sep 2022 - Sep 2023)
Oncology Cell Therapy/Tumour Cell Targeting at GSK

Qualifications

• BSc in Biological Sciences, University of Warwick, UK

Honours and awards

• School of Life Sciences Year 1 Class Prize for Top Performance- Biological Sciences
• School of Life Sciences Year 2 Class Prize for Top Performance- Biological Sciences
• School of Life Sciences Placement Student of the year
• School of Life Sciences Year 3 Class Prize for Top Performance- Biological Sciences

Key publications

• Lewis JM, Dutton O, Mistry T, Sagona AP. Novel Burkholderia-Targeting Lytic Phage Rocko Preferentially Kills Stationary Phase Bacterial Cells. PHAGE: Therapy, Applications, and Research. 2026;7(3):207-218. doi:10.1177/26416549261465080